Immunotherapy for kidney cancer treatment

Kidney cancer is a common malignant tumor disease. In recent years, with the change of people's lifestyle, the incidence of kidney cancer has tended to increase, so we must be particularly vigilant in life. In the treatment of kidney cancer, in addition to the common surgery and radiotherapy, drug therapy is also commonly used and plays an important role in the treatment of kidney cancer. So what are the immune drugs for the treatment of kidney cancer?

Drugs for the treatment of kidney cancer mainly include chemotherapy drugs and traditional Chinese medicine. Especially in recent years, with the continuous development of medical level, some drugs have emerged in an endless stream, among which there are good and bad ones, it is difficult to distinguish the true from the false, and the efficacy varies. For the majority of cancer patients, due to their lack of professional knowledge, they often do not know how to choose from a variety of new drugs, and inevitably take detours and seek medical treatment randomly, which eventually leads to loss of both life and money. The FDA has granted the PD-1 blocker drugs nivolumab and MK-3475 breakthrough therapy titles. In recent early clinical trials on melanoma, both have shown unprecedented good efficacy (nivolumab can also be effectively used to treat kidney cancer and lung cancer).
Therefore, this also reminds the majority of patients to choose appropriate treatment plans based on their own conditions. At the same time, they should also learn more about the pros and cons of each treatment method to better treat the disease.